White Papers
xBxBio: Regulatory Requirements
xBxBio is a software as a medical device (SaMD) company that specializes in developing the xBxBio
platform for drug discovery. The xBxBio platform uses artificial intelligence and machine learning
algorithms to predict drug efficacy and toxicity, and to optimize drug discovery workflows. The platform
is intended for use by researchers and drug development teams in the pharmaceutical industry.
xBxBio: Quality
The xBxBio application is a predictive modeling engine for drug discovery and development. It is facilitated by the innovative and proprietary data mining and assemblage technology based on structureand chemical properties, both from predictive Software, empirical data, and published data to develop a multidimensional modeling system to improve the accuracy of the model and, in turn, increase successes designing new pharmaceutical agents and applications.
xBxBio: Engineering
Drug research is a complex process that involves extensive experimentation, data analysis, andcollaboration between various stakeholders. The xBxBio platform is a software engineering tool that has been designed specifically for drug research. This whitepaper will explore the role of softwareengineering in the xBxBio platform, and how it can help accelerate drug research and development.
xBxBio: Computational Pharmacology
This paper discusses the importance of computational pharmacology in drug discovery and development.
We highlight this multidisciplinary field's various applications, recent advancements, and challenges.
Additionally, we explore the potential integration of artificial intelligence (AI) and machine learning
(ML) further to enhance computational pharmacology's contributions to drug discovery.
xBxBio: In Vitro Techniques in Drug Discovery
This paper discusses the role of in vitro techniques in drug discovery, the advancements made in recent
years, and the challenges researchers face. We also explore integrating in vitro methods with artificial
intelligence (AI) and machine learning (ML) approaches to improve the drug discovery process.
xBxBio: Big Data
The field of Big Data is rapidly evolving with the integration of technologies like virtual reality (VR),
augmented reality (AR), machine learning (ML), and artificial intelligence (AI). These technologies can be
leveraged in bio analytics to enhance the analysis of complex biological systems. This white paper will
explore the use of xBxBio's platform for big data bioanalytical research utilizing VR, AR, ML, and AI.